Synthesis and carbonic anhydrase inhibitory properties of 1,3-dicarbonyl derivatives of methylaminobenzene-sulfonamide

References

• Hewett-Emmet D. Evolution and distribution of the carbonic anhydrase gene families. In: Chegwidden WR, Edwrds Y, Carter N, eds. The carbonic anhydrase – new horizons. Basel: Birkhauser Verlag; 2000:29–78
   Google Scholar
• Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev 2003;23:146–89
   PubMed Web of Science ®Google Scholar
• Vullo D, Voipio J, Innocenti A, et al. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides. Bioorg Med Chem Lett 2005;15:971–6
   PubMed Web of Science ®Google Scholar
• Nishimori I, Minakuchi T, Onishi S, et al. Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors. J Med Chem 2007;50:381–8
   PubMed Web of Science ®Google Scholar
• Gitto R, Damiano FM, Mader P, et al. Synthesis, structure-activity relationship studies, and X-ray crystallographic analysis of arylsulfonamides as potent carbonic anhydrase inhibitors. J Med Chem 2012;55:3891–9
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem 2007;15:4336–50
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors and activators for novel therapeutic applications. Future Med Chem 2011;3:1165–80
   PubMed Web of Science ®Google Scholar
• Ekinci D, Çavdar H, Durdagi S, et al. Structure-activity relationships for the interaction of 5,10-dihydroindeno[1,2-b] indole derivatives with human and bovine carbonic anhydrase isoforms I, II, III, IV and VI. Eur J Med Chem 2012;49:68–73
   PubMed Web of Science ®Google Scholar
• Lach L, Pasquet M-J, Chabanne M. A general route to unsubstituted N-aryl and heteroarylaminobenzenesulfonamides. Tetrahedron Lett 2011;52:1882–7
   Google Scholar
• Perrin KA, Huang J, McElroy EB, et al. Defining the interactions between DNA and the exonuclease domain of DNA-polymerases. J Am Chem Soc 1994;116:7427–8
   Google Scholar
• Campbell JA, Hart D. Tert-butyl [[2-(trimethylsilyl)ethyl]sulfonyl]carbamate – a new reagent for use in mitsunobu reactions. J Org Chem 1993;58:2900–3
   Web of Science ®Google Scholar
• Gennari C, Longari C, Ressel S, et al. Synthesis of chiral vinylogous sulfonamidopeptides (vs-peptides). Eur J Org Chem 1998;6:945–59
   Google Scholar
• Arya P, Quin HS. Advances in asymmetric enolate methodology. Tetrahedron 2000;56:917–47
   Web of Science ®Google Scholar
• Scozzafava A, Owa T, Mastrolorenzo A, Supuran CT. Anticancer and antiviral sulphonamides. Curr Med Chem 2003;10:925–53
   PubMed Web of Science ®Google Scholar
• Mustafa G, Khan IU, Ashraf M, et al. Synthesis of new sulfonamides as lipoxygenase inhibitors. Bioorg Med Chem 2012;20:2535–9
   PubMedGoogle Scholar
• Rauf A, Ahmed F, Qureshi AM, et al. Synthesis and urease inhibition studies of barbituric and thiobarbituric acid derived sulphonamides. J Chin Chem Soc 2011;58:528–37
   Web of Science ®Google Scholar
• Kozlovskaya TF, Strakov AY, Petrova MV, et al. Reactions of 2-formyldimedone with some nitrogeneous nucleophiles. Latvijas Kimijas Zurnals 1991;2:179–84
   Google Scholar
• Gadad AK, Mahajanshetti CS, Nimbalkar S, Raichurkar A. Synthesis and antibacterial activity of some 5-guanylhydrazone/thiocyanato-6-arylimidazo[2,1-b]-1,3,4-thiadiazole-2-sulfonamide derivatives. Eur J Med Chem 2000;35:853–67
   PubMed Web of Science ®Google Scholar
• Maren TH. A simplified micromethod for the determination of carbonic anhydrase and its inhibitors. J Pharm Exp Ther 1960;130:2629–34
   Web of Science ®Google Scholar
• Li JJ, Anderson D, Burton EG, et al. 1,2-Diarylcyclopentenes as selective cyclooxygenase-2 inhibitors and orally active antiinflammatory agents. J Med Chem 1995;38:4570–8
   PubMed Web of Science ®Google Scholar
• Yoshino H, Ueda N, Niijma J, et al. Novel sulfonamides as potential, systemically active antitumor agents. J Med Chem 1992;35:2496–7
   PubMed Web of Science ®Google Scholar
• Renzi G, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: topical sulfonamide antiglaucoma agents incorporating secondary amine moieties. Bioorg Med Chem Lett 2000;10:673–6
   PubMed Web of Science ®Google Scholar
• Kasımoğulları R, Bülbül M, Arslan BS, Gökçe B. Synthesis, characterization and antiglaucoma activity of some novel pyrazole derivatives of 5-amino-1,3,4-thiadiazole-2-sulfonamide. Eur J Med Chem 2010;45:4769–73
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–81
   PubMed Web of Science ®Google Scholar
• Sugrue MF. Pharmacology and ocular hypotensive properties of topical carbonic anhydrase inhibitors. Prog Ret Eye Res 2000;19:87–112
   PubMed Web of Science ®Google Scholar
• Ozensoy O, Arslan O, Oznur SS. A new method for purification of carbonic anhydrase isozymes by affinity chromatography. Biochemistry (Mosc) 2004;69:216–19
   PubMed Web of Science ®Google Scholar
• Maresca A, Temperini C, Pochet L, et al. Deciphering the mechanism of carbonic anhydrase ınhibition with coumarins and thiocoumarins. J Med Chem 2010;53:335–44
   PubMed Web of Science ®Google Scholar
• Arslan O, Cakır U, Ugras HI. Synthesis of new sulfonamide inhibitors of carbonic anhydrase. Biochemistry (Mosc) 2002;67:1055–7
   PubMed Web of Science ®Google Scholar
• Winum JY, Vullo D, Casini A, et al. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors. J Med Chem 2003;46:2197–204
   PubMed Web of Science ®Google Scholar
• Hen N, Bialer M, Yagen B, et al. Anticonvulsant 4-aminobenzenesulfonamide derivatives with branched-alkylamide moieties: X-ray crystallography and inhibition studies of human carbonic anhydrase isoforms I, II, VII, and XIV. J Med Chem 2011;54:3977–81
   PubMed Web of Science ®Google Scholar
• Wagner J, Avvaru BS, Robbins AH, et al. Coumarinyl-substituted sulfonamides strongly inhibit several human carbonic anhydrase isoforms: solution and crystallographic investigations. Bioorg Med Chem 2010;18:4873–8
   PubMed Web of Science ®Google Scholar
• Arslan O, Küfrevioğlu OI, Nalbantoğlu B. Synthesis and investigation of inhibition effects of new carbonic anhydrase inhibitors. Bioorg Med Chem 1997;5:515–18
   PubMedGoogle Scholar
• Aydemir T, Kavrayan D. Purification and characterization of glutathione-s-transferase from chicken erythrocyte. Artif Cells Blood Substit Immobil Biotechnol 2009;37:92–100
   PubMed Web of Science ®Google Scholar
• Gencer N, Arslan O. Purification human PON1 (Q192) and PON1(R192) isoenzymes by hydrophobic interaction chromatography and investigation of the inhibition by metals. J Chrom B Anal Tech Biomed Life Sci 2009;877:134–40
   PubMed Web of Science ®Google Scholar
• Gencer N, Ergün A, Demir D. In vitro effects of some anabolic compounds on erythrocyte carbonic anhydrase I and II. J Enzyme Inhib Med Chem 2012;27:208–10
   PubMed Web of Science ®Google Scholar
• Sinan S, Gencer N, Turan Y, Arslan O. In vitro inhibition of the carbonic anhydrase from saanen goat (Capra hircus) with pesticides. Pest Biochem Phys 2007;88:307–11
   Web of Science ®Google Scholar
• Kiranoglu S, Sinan S, Gencer N, et al. In vivo effects of oral contraceptives on paraoxonase, catalase and carbonic anhydrase enzyme activities on mouse. Biolog Pharm Bull 2007;30:1048–51
   PubMed Web of Science ®Google Scholar
• Sinan S, Kockar F, Gencer N, et al. Amphenicol and macrolide derived antibiotics inhibit paraoxonase enzyme activity in human serum and human hepatoma cells (HepG2) in vitro. Biochemistry (Mosc) 2006;71:46–50
   PubMed Web of Science ®Google Scholar
• Erol K, Gençer N, Arslan M, Arslan O. Purification, characterization, and investigation of in vitro inhibition by metals of Paraoxonase from different sheep breeds. Artif Cells Blood Substit Immobil Biotechnol 2012; In press. DOI: 10.3109/10731199.2012.696065
   Google Scholar
• Demir D, Gençer N, Er A. Purification and characterization of prophenoloxidase from Galleria mellonella L. Artif Cells Blood Substit Immobil Biotechnol 2012;40:369–77
   PubMedGoogle Scholar
• Bytyqi-Damoni A, Genç H, Zengin M, et al. In vitro effect of novel β-lactam compounds on xanthine oxidase enzyme activity. Artif Cells Blood Substit Immobil Biotechnol 2012;40:369–77
   PubMed Web of Science ®Google Scholar
• Gökçe B, Gençer N, Arslan O, et al. Evaluation of in vitro effects of some analgesic drugs on erythrocyte and recombinant carbonic anhydrase I and II. J Enzyme Inhib Med Chem 2012;27:37–42
   PubMed Web of Science ®Google Scholar
• Ekinci D, Al-Rashida M, Abbas G, et al. Chromone containing sulfonamides as potent carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:744–7
   PubMed Web of Science ®Google Scholar
• Senturk M, Ekinci D, Goksu S, Supuran CT. Effects of dopaminergic compounds on carbonic anhydrase isozymes I, II, and VI. J Enzyme Inhib Med Chem 2012;27:365–9
   PubMed Web of Science ®Google Scholar
• Cankaya M, Aktas M, Kuzucu M, et al. Effects of some drugs on human cord blood erythrocyte carbonic anhydrases I and II: an in vitro study. J Enzyme Inhib Med Chem 2012;27:641–5
   PubMed Web of Science ®Google Scholar
• Sayin D, Cakir DT, Gencer N, Arslan O. Effects of some metals on paraoxonase activity from shark Scyliorhinus canicula. J Enzyme Inhib Med Chem 2012;27:595–8
   PubMed Web of Science ®Google Scholar